Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
ACCELERON PHARMA INC (XLRN) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/22/2021 4 Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 34,499 shares @ $0
Disposed/sold 10,000 options to buy @ $27.97, valued at $279.7k
Disposed/sold 7,500 options to buy @ $30.17, valued at $226.3k
Disposed/sold 7,500 options to buy @ $40.61, valued at $304.6k
Disposed/sold 10,000 options to buy @ $41.2, valued at $412k
Disposed/sold 7,500 options to buy @ $41.64, valued at $312.3k
Disposed/sold 8,185 options to buy @ $52.99, valued at $433.7k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
11/22/2021 4 Malik Kemal (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 1,622 shares @ $0
Disposed/sold 17,956 options to buy @ $52.61, valued at $944.7k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
11/22/2021 4 Hite Christopher (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 930 shares @ $0
Disposed/sold 10,267 options to buy @ $92.09, valued at $945.5k
Disposed/sold 1,848 options to buy @ $115.53, valued at $213.5k
11/22/2021 4 Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 1,622 shares @ $0
Disposed/sold 10,000 options to buy @ $35.34, valued at $353.4k
Disposed/sold 1,875 options to buy @ $40.61, valued at $76.1k
Disposed/sold 3,750 options to buy @ $41.64, valued at $156.2k
Disposed/sold 4,085 options to buy @ $52.99, valued at $216.5k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
11/22/2021 4 MCCOURT Thomas A (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 6,044 shares @ $0
Disposed/sold 7,500 options to buy @ $41.64, valued at $312.3k
Disposed/sold 8,185 options to buy @ $52.99, valued at $433.7k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
11/22/2021 4 Kearney Terrence C (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 6,749 shares @ $0
Disposed/sold 7,500 options to buy @ $40.61, valued at $304.6k
Disposed/sold 4,665 options to buy @ $41.2, valued at $192.2k
Disposed/sold 7,500 options to buy @ $41.64, valued at $312.3k
Disposed/sold 8,185 options to buy @ $52.99, valued at $433.7k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
11/22/2021 4 Hamill Laura (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 474 shares @ $0
Disposed/sold 9,339 options to buy @ $101.88, valued at $951.5k
Disposed/sold 941 options to buy @ $115.53, valued at $108.7k
11/22/2021 4 Nader Francois (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 6,749 shares @ $0
Disposed/sold 10,000 options to buy @ $27.97, valued at $279.7k
Disposed/sold 7,500 options to buy @ $30.17, valued at $226.3k
Disposed/sold 10,000 options to buy @ $34.14, valued at $341.4k
Disposed/sold 7,500 options to buy @ $40.61, valued at $304.6k
Disposed/sold 576 options to buy @ $41.2, valued at $23.7k
Disposed/sold 20,000 options to buy @ $41.48, valued at $829.6k
Disposed/sold 7,500 options to buy @ $41.64, valued at $312.3k
Disposed/sold 8,185 options to buy @ $52.99, valued at $433.7k
Disposed/sold 3,222 options to buy @ $115.53, valued at $372.2k
11/22/2021 4 Veness Adam M (SVP, General Counsel and Sec.) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 23,423 shares @ $0
Disposed/sold 6,700 options to buy @ $40.37, valued at $270.5k
Disposed/sold 7,650 options to buy @ $40.61, valued at $310.7k
Disposed/sold 8,500 options to buy @ $41.64, valued at $353.9k
Disposed/sold 24,334 options to buy @ $52.99, valued at $1.3M
Disposed/sold 18,806 options to buy @ $115.53, valued at $2.2M
11/22/2021 4 KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 18,509 shares @ $0
Disposed/sold 25,000 options to buy @ $40.61, valued at $1M
Disposed/sold 25,500 options to buy @ $41.64, valued at $1.1M
Disposed/sold 24,334 options to buy @ $52.99, valued at $1.3M
Disposed/sold 20,896 options to buy @ $115.53, valued at $2.4M
11/22/2021 4 Backstrom Jay T. (EVP, Research and Development) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 21,233 shares @ $0
Disposed/sold 96,963 options to buy @ $52.61, valued at $5.1M
Disposed/sold 20,896 options to buy @ $115.53, valued at $2.4M
11/22/2021 4 MCLAUGHLIN KEVIN F (SVP, CFO and Treasurer) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 10,681 shares @ $0
Disposed/sold 2,663 options to buy @ $30.17, valued at $80.3k
Disposed/sold 11,262 options to buy @ $40.61, valued at $457.3k
Disposed/sold 20,500 options to buy @ $41.64, valued at $853.6k
Disposed/sold 24,334 options to buy @ $52.99, valued at $1.3M
Disposed/sold 18,806 options to buy @ $115.53, valued at $2.2M
11/22/2021 4 Dable Habib J (CEO and President) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Unknown transaction of 98,450 shares @ $0
Disposed/sold 250,000 options to buy @ $35.04, valued at $8.8M
Disposed/sold 108,800 options to buy @ $40.61, valued at $4.4M
Disposed/sold 106,400 options to buy @ $41.64, valued at $4.4M
Disposed/sold 84,720 options to buy @ $52.99, valued at $4.5M
Disposed/sold 64,361 options to buy @ $115.53, valued at $7.4M
11/12/2021 4 Veness Adam M (SVP, General Counsel and Sec.) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Exercised 4,500 options to buy @ $29.37, valued at $132.2k
09/27/2021 4 KANGO SUJAY (EVP, Chief Commercial Officer) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 5,000 shares @ $175, valued at $875k
Exercised 5,000 options to buy @ $40.61, valued at $203.1k
09/24/2021 4 MCLAUGHLIN KEVIN F (SVP, CFO and Treasurer) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 18,647 shares @ $160.26, valued at $3M
Sold 983 shares @ $161.26, valued at $158.5k
Sold 5,370 shares @ $160.38, valued at $861.2k
Exercised 2,500 options to buy @ $30.17, valued at $75.4k
Exercised 9,800 options to buy @ $40.61, valued at $398k
Exercised 7,330 options to buy @ $41.64, valued at $305.2k
Exercised 5,200 options to buy @ $40.61, valued at $211.2k
Exercised 170 options to buy @ $41.64, valued at $7.1k
09/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/09/2021 4 Veness Adam M (SVP, General Counsel and Sec.) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Paid exercise price by delivering 587 shares @ $129.36, valued at $75.9k
Sold 6 shares @ $130, valued at $780
Sold 1,407 shares @ $130, valued at $182.9k
07/02/2021 4 Dable Habib J (CEO and President) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 11,845 shares @ $125.15, valued at $1.5M
Sold 9,194 shares @ $125.81, valued at $1.2M
Sold 23,160 shares @ $126.85, valued at $2.9M
Sold 4,560 shares @ $127.89, valued at $583.2k
Sold 9,055 shares @ $128.82, valued at $1.2M
Sold 29,140 shares @ $126.69, valued at $3.7M
Sold 11,458 shares @ $127.51, valued at $1.5M
Sold 1,588 shares @ $128.21, valued at $203.6k
Exercised 57,814 options to buy @ $35.04, valued at $2M
Exercised 42,186 options to buy @ $35.04, valued at $1.5M
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2021 4 MCCOURT Thomas A (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 2,127 shares @ $118.39, valued at $251.8k
Sold 4,030 shares @ $119.36, valued at $481k
Sold 1,143 shares @ $120.16, valued at $137.3k
Sold 200 shares @ $121.23, valued at $24.2k
Exercised 7,500 options to buy @ $40.61, valued at $304.6k
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 11,223 shares @ $140.13, valued at $1.6M
Sold 641 shares @ $141.15, valued at $90.5k
Exercised 5,000 options to buy @ $35.34, valued at $176.7k
Exercised 1,875 options to buy @ $41.64, valued at $78.1k
Exercised 2,050 options to buy @ $52.99, valued at $108.6k
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Smith Karen L. (Director) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Sold 1,201 shares @ $134.54, valued at $161.6k
Sold 2,987 shares @ $136.22, valued at $406.9k
Sold 3,796 shares @ $136.92, valued at $519.7k
Sold 941 shares @ $137.92, valued at $129.8k
Exercised 5,000 options to buy @ $35.34, valued at $176.7k
Exercised 1,875 options to buy @ $41.64, valued at $78.1k
Exercised 2,050 options to buy @ $52.99, valued at $108.6k
03/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Veness Adam M (SVP, General Counsel and Sec.) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Granted 4,868 shares @ $0
Granted 18,806 options to buy @ $115.53, valued at $2.2M
02/02/2021 4 MCLAUGHLIN KEVIN F (SVP, CFO and Treasurer) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Granted 4,868 shares @ $0
Granted 18,806 options to buy @ $115.53, valued at $2.2M
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/02/2021 4 Backstrom Jay T. (EVP, Research and Development) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Granted 5,409 shares @ $0
Granted 20,896 options to buy @ $115.53, valued at $2.4M
02/02/2021 4 Dable Habib J (CEO and President) has filed a Form 4 on ACCELERON PHARMA INC
Txns: Granted 16,662 shares @ $0
Granted 64,361 options to buy @ $115.53, valued at $7.4M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy